Effect of Rasnadi Niruha Basti in the management of high blood sugar

A clinical efficacy of Rasnadi Niruha Basti in the management of Madhumeha (Type 2 Diabetes Mellitus)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/044786

Enrollment

Registered

2022-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having classical sign and symptoms of Madhumeha (Type 2 Diabetes Mellitus) as per Ayurvedic classics as well as modern medicine. 2. Age: 30- 50 years 3. Newly diagnosed patients with Plasma sugar level between: Fasting- 126mg/dl- 160mg/dl Postprandial- 200mg/dl- 250mg/dl 4. HbA1c level between: 6.5% to 9.0% 5. Obese patients having BMI: > 23Kg/m2 6. Patients who are fit for Basti Karma as per ayurvedic classics.

Exclusion criteria

Exclusion criteria: 1. Age: 50yrs 2. HbA1c level: 9.0% 3. FBS level >160mg /dl and PPBS level >250mg/dl 4. Krisha or thin patients with BMI: Equal to or less than 23Kg/m2 5. Patients suffering from IDDM (Insulin dependent Diabetes Mellitus), Juvenile Diabetes or Gestational Diabetes. 6. Patients having drug and chemical induced Type 2 Diabetes like glucocorticoids induced or thyroid hormone induced etc. 7. Patients with complications of Diabetes like Diabetic ketoacidosis, Diabetic coma, Diabetic retinopathy, Diabetic neuropathy and Diabetic nephropathy. 8. Patients suffering from other systemic diseases. 9. Patients suffering from any current acute illness. 10. Patients having congenital physiological anomalies, surgical interventions and any truma. 11. Patients who are contraindicated for Basti Karma.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Rasnadi Niruha Basti in the management of Madhumeha (Type 2 Diabetes Mellitus).Timepoint: At baseline, 21st day, 35th day, 56th day and after 86th day.	—

Secondary

Measure	Time frame
Ã¢â?¬Â¢ To access clinical presentation of Madhumeha (Type 2 Diabetes Mellitus) Ã¢â?¬Â¢ To access Changes in Madhumeha (Type 2 Diabetes Mellitus) features and investigative procedures. Timepoint: 3 Months	—

Countries

India

Contacts

Public ContactPooja

Shri Krishna Government Ayurvedic College and Hospital

drashishhmehta@gmail.com8950375285

Outcome results